Insiders · LEXX

Christopher Bunka

Chief Executive Officer, Director at Lexaria Bioscience Corp. (LEXX)

Christopher Bunka has filed 10 insider reports with the SEC since September 2021, as chief Executive Officer and director at Lexaria Bioscience Corp. (LEXX). Christopher Bunka made no open-market purchases or sales in the last 12 months. The latest filing, on March 18, 2026, reports gift at Lexaria Bioscience Corp. (LEXX).

Filings
10
Companies
1
Bought on market
$104K
Sold on market
None

Companies where Christopher Bunka is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Lexaria Bioscience Corp. logo
LEXX
Lexaria Bioscience Corp.
Chief Executive Officer, Director273,543$104K$1.57$4.03+157%Mar 18, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Christopher Bunka with

Other insiders at the same companies

Questions about Christopher Bunka

What is Christopher Bunka's role at Lexaria Bioscience Corp.?
Christopher Bunka reports to the SEC as chief Executive Officer and director at Lexaria Bioscience Corp. (LEXX), according to the latest filing on March 18, 2026.
How many shares does Christopher Bunka own?
After the latest filing that states it, Christopher Bunka directly owned 273,543 shares of Lexaria Bioscience Corp. (LEXX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Christopher Bunka bought or sold stock recently?
The most recent open-market purchase was on July 30, 2025: bought 27,500 shares of Lexaria Bioscience Corp. (LEXX) for $25.2K at an average of $0.92.
How do I get alerts when Christopher Bunka files?
Follow Christopher Bunka on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Christopher Bunka (SEC CIK 0001103780). Totals count each trade once, skipping amendments whose original is on file, from Sep 2, 2021 on. View on SEC EDGAR · Get this as JSON